Silence Therapeutics (SLN) Common Equity (2018 - 2026)
Silence Therapeutics' Common Equity was $38.47 million in the quarter ended Jun 30, 2026, down 59.1% from $94.16 million a year earlier and down 22.1% from the prior quarter.
Powered by 
Analysis
Silence Therapeutics (SLN) Common Equity (2018 - 2026) Analysis & Trends
As of Dec 31, 2025, Common Equity at Silence Therapeutics came in at $62.3 million, down 53.5% from the prior year.
- Common Equity shows a five-year compound annual growth rate of 39.9% (years ended Dec 2020 to Dec 2025).
- In earlier years, Common Equity was $134.02 million in the year ended Dec 31, 2024 (+509.4%), $21.99 million in the year ended Dec 31, 2023 (-19.2%), $27.22 million in the year ended Dec 31, 2022 (+132.0%) and $11.73 million in the year ended Dec 31, 2021 (+0.8%).
- The figure for the quarter ended Jun 30, 2026 marks the lowest quarterly Common Equity since the quarter ended Dec 31, 2023.
- Compared with a year earlier, Common Equity has declined for six straight quarters, with growth averaging 37.3% over the last seven quarters.
- The best year-over-year quarter for Common Equity over five years was the quarter ended Dec 31, 2024 (growth of 533.3%); the worst was the quarter ended Jun 30, 2026 (a decline of 59.1%).
- Per Business Quant data, SLN's Common Equity in the three quarters before the quarter ended Jun 30, 2026 was $49.4 million (quarter ended Mar 31, 2026), $62.3 million (quarter ended Dec 31, 2025) and $74.06 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Silence Therapeutics | 529.16 Mn | 457.06 Mn | - | 38.47 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 38.47 Mn |
| Mar 31, 2026 | 49.40 Mn |
| Dec 31, 2025 | 62.30 Mn |
| Sep 30, 2025 | 74.06 Mn |
| Jun 30, 2025 | 94.16 Mn |
| Mar 31, 2025 | 112.74 Mn |
| Dec 31, 2024 | 134.02 Mn |
| Sep 30, 2024 | 126.70 Mn |
| Jun 30, 2024 | 142.53 Mn |
| Mar 31, 2024 | 156.76 Mn |
| Dec 31, 2023 | 21.16 Mn |
| Dec 31, 2022 | 25.89 Mn |
| Dec 31, 2021 | 11.49 Mn |
| Dec 31, 2020 | 11.96 Mn |
| Dec 31, 2019 | 26.88 Mn |
| Dec 31, 2018 | 45.11 Mn |
API Access
Silence Therapeutics Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=SLN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "SLN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=SLN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();